Equities

Beauty Farm Medical & Health Industry Inc

Beauty Farm Medical & Health Industry Inc

Actions
Health CareHealth Care Providers
  • Price (HKD)17.38
  • Today's Change0.300 / 1.76%
  • Shares traded27.50k
  • 1 Year change+37.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beauty Farm Medical & Health Industry Inc is an investment holding company that mainly provides beauty and health management services. The Company's beauty and health management services include beauty and wellness services, aesthetic medical services and subhealth medical services. The Company uses nursing technology, product instruments, quality control processes and service standards to provide beauty and body care services. The Company operates brands such as Beauty Farm, Palaispa, Neology, CellCare, and others. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)2.41bn
  • Net income in HKD235.51m
  • Incorporated2022
  • Employees3.93k
  • Location
    Beauty Farm Medical & Health Industry IncNo.1089 Dongdaming RoadHongkou District, Unit 1206, 12th FloorSHANGHAI ChinaCHN
  • Websitehttp://www.beautyfarm.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
EC Healthcare4.21bn-18.95m829.65m2.61k--0.4231.290.197-0.016-0.0163.551.650.77366.8717.731,612,805.000.28834.510.46017.6984.1886.570.37276.180.84661.130.400395.138.6617.85-127.20---10.92-46.59
Perfect Medical Health Management Ltd1.39bn315.80m3.35bn1.27k10.626.746.552.410.25140.25141.110.3961.113.5924.761,094,532.0024.6524.6441.9139.2298.0298.1222.2824.391.34--0.35199.270.29353.080.0513-0.20350.3752-2.78
Beauty Farm Medical & Health Indstry Inc2.41bn235.51m4.03bn3.93k16.714.526.591.671.021.0210.473.780.68886.7057.59612,160.107.21--19.87--46.00--10.47--0.8561--0.4085--31.16--109.15------
Fu Shou Yuan International Group Ltd2.37bn671.71m8.95bn2.40k13.051.379.783.780.29580.29581.042.810.2570.246415.89979,297.608.7911.9711.1815.4793.6893.0934.2038.363.21--0.040329.8521.029.7420.1410.13-16.2717.24
Data as of Nov 22 2024. Currency figures normalised to Beauty Farm Medical & Health Industry Inc's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

1.35%Per cent of shares held by top holders
HolderShares% Held
E Fund Management Co., Ltd.as of 30 Jun 20242.91m1.23%
China Universal Asset Management Co., Ltd.as of 30 Jun 2024122.00k0.05%
FIL Investment Management (Hong Kong) Ltd.as of 30 Sep 202469.00k0.03%
China Southern Asset Management Co., Ltd.as of 30 Jun 202430.50k0.01%
SSgA Funds Management, Inc.as of 07 Nov 202423.00k0.01%
Euromobiliare Asset Management SGR SpAas of 30 Sep 202420.00k0.01%
Dimensional Fund Advisors LPas of 07 Nov 202417.50k0.01%
DFA Australia Ltd.as of 30 Sep 2024176.000.00%
FIL Investments Internationalas of 31 Jul 20240.000.00%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.